• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES GORE® EXCLUDER® AAA ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES GORE® EXCLUDER® AAA ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Catalog Number PXC121000J
Device Problem Insufficient Information (3190)
Patient Problems Aneurysm (1708); Seroma (2069)
Event Date 07/10/2017
Event Type  Injury  
Manufacturer Narrative
The review of the manufacturing paperwork verified that this lot met all pre-release specifications.According to the gore® excluder® aaa endoprosthesis instructions for use (ifu), adverse events that may occur and / or require intervention include, but are not limited to aneurysm enlargement and surgical conversion.Device udi lot/serial: (b)(4), udi: (b)(4).Lot/serial: (b)(4), udi: (b)(4).Lot/serial: (b)(4), udi: (b)(4).
 
Event Description
On (b)(6) 2016, the patient underwent endovascular repair of an abdominal aortic aneurysm.A non-gore manufactured endoprosthesis (zenith device, cook medical) was deployed as a main body and gore® excluder® aaa endoprostheses contralateral leg and iliac extender components were implanted as device legs.The patient tolerated the procedure.A later follow-up study revealed aneurysm enlargement (amount of enlargement is unknown).On (b)(6) 2017, an open abdominal surgery was performed to treat the aneurysm enlargement.The existing endoprostheses were partially removed and replaced with a surgical graft.During the procedure, it was confirmed that seroma had been accumulated into the aneurysm sac (¿something that was accumulated in the aneurysm sac¿ was neither blood nor hematoma).The patient tolerated the procedure.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® EXCLUDER® AAA ENDOPROSTHESIS
Type of Device
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
Manufacturer (Section G)
MEDICAL SUNNYVALE B/P
1327 orleans drive
sunnyvale CA 94089
Manufacturer Contact
yutaka uchiya
1500 n. 4th street
flagstaff, AZ 
9285263030
MDR Report Key6776321
MDR Text Key82112829
Report Number2953161-2017-00157
Device Sequence Number1
Product Code MIH
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P020004
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Reporter Occupation Physician
Type of Report Initial
Report Date 07/20/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date11/30/2018
Device Catalogue NumberPXC121000J
Device Lot Number14616463
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received Not provided
Initial Date FDA Received08/09/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured12/29/2015
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
PXL161007J/14674348 AND PXL161207J/13257900
Patient Outcome(s) Hospitalization; Required Intervention;
-
-